Holen Sie sich die Stockscreener-App
1.15
1.71%
-0.02
Handel nachbörslich:
1.16
0.01
+0.87%
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Apollomics Inc. Class A (APLM) Stock Price & News - Syfe
Cardiol Therapeutics (TSX:CRDL): Why Is The MAVERIC Trial Getting Bigger? - Kalkine Media
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - GlobeNewswire Inc.
HLS Therapeutics (TSX:HLS) Stock Falls 7.38% Despite Expanded Share Buyback - kalkine.ca
Why Custom Health Holdings Inc. (CHLT) is buying pharmacies and dispensing technology after its TSX debut - kalkine.ca
Diluted net income available to common stockholders of Cardiol Therapeutics Inc. Class A – HAN:CT9 - TradingView
Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting - kalkine.ca
Cardiol Therapeutics Inc. (CRDL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada
ME Therapeutics Holdings (CN:METX:CNX) Stock Rebounds 14.29%: In Vivo CAR-T and mRNA STING Program Pacing, Micro-Cap Liquidity Dynamics, and Preclinical Biotech Re-Rating Examined - kalkine.ca
How TelyRx (TSX:TELY) Grew Revenue 143% in a Year - kalkine.ca
Cardiol Therapeutics Inc. (CRDL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tejara Capital Holds 5.3% Stake in Cardiol Therapeutics (NASDAQ: CRDL), Owning 6.38 Million Shares - Kalkine Media
Fund manager reports 6.4M Cardiol Therapeutics (NASDAQ: CRDL) shares - Stock Titan
German investor discloses stake in Werewolf Therapeutics (NASDAQ: HOWL) - Stock Titan
HLS Therapeutics Inc. Stock Slips 0.99%: Cardiovascular Market Adoption Friction, Specialty Pharma Valuation Sensitivity, and Revenue Transition Weigh on Sentiment - kalkine.ca
TSXV:GSD Edges Higher as Devonian Targets NYSE American Listing and Advances Thykamine Development - kalkine.ca
[Form 4] New Fortress Energy Inc. Insider Trading Activity - Stock Titan
Nelnet (NYSE: NNI) director’s stake climbs to 31,953 shares - Stock Titan
Cardiol Therapeutics (Nasdaq: CRDL) opens path to raise cash for heart drug trials - Stock Titan
How Jolt Health (CN:JOLT.X) Could Bring Fresh Energy to Canada's Healthcare Micro-Caps - kalkine.ca
Why Adaptogenics Health (CN:ADPT) Could Ride Growing Interest in Wellness Companies - kalkine.ca
Alta Partners reports 2.1M Envoy Medical (COCH) shares - stocktitan.net
Cardiol Therapeutics: Q1 2027 Readout Will Be Make-Or-Break For MAVERIC (NASDAQ:CRDL) - Seeking Alpha
Cardiol Therapeutics (TSX:CRDL) Slides 12.34% as Volatility Returns and Investors Reassess the Clinical-Stage Risk - kalkine.ca
Cardiol Therapeutics Stock Faces Renewed Pressure as Biotech Risk and Clinical Uncertainty Weigh on Sentiment - kalkine.ca
Cardiol Therapeutics (CRDL) sets terms with new manufacturing and drug ingredient partners - Stock Titan
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com Nigeria
CRDL: Cardiol Therapeutics IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus - TradingView
Cardiol Therapeutics files $150 million shelf prospectus - Investing.com
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com Canada
Cardiol Therapeutics files $150 million shelf prospectus - Investing.com India
New 25‑month shelf lets Cardiol Therapeutics (CRDL) line up future financing - Stock Titan
Cardiol Therapeutics files US$150M base shelf prospectus - TradingView
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PR Newswire
Cardiol Therapeutics Inc. (NASDAQ: CRDL) to Host Fireside Chat on September 14 at H.C. Wainwright Investment Conference - Kalkine Media
Cardiol Therapeutics (NASDAQ: CRDL) lines up new shelf to fund drug trials - Stock Titan
Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln - TradingView
Cardiol Therapeutics Inc. Class A (TSX:CRDL) Gains Momentum as Cardiovascular Drug Pipeline Progress Strengthens Investor Optimism - kalkine.ca
US$150M filing does not mean a sale is happening. Cardiol may offer securities later. - Stock Titan
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com UK
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PR Newswire Canada
Cardiol Therapeutics (TSX:CRDL) Healthcare Stock Latest Update - Kalkine Media
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Heart-drug developer Cardiol Therapeutics (CRDL) heads to a major New York investor conference - Stock Titan
Cardiol Therapeutics will join a heart-disease drug chat in New York Sept. 14 - Stock Titan
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
ADAG Stock Price, Quote & News - Syfe
Global-E Online (GLBE) officer to sell 12,500 shares in 2026 - Stock Titan
Cardiol Therapeutics Inc. (TSX:CRDL) Climbs 10.18% as Phase III Catalyst and CardiolRx Momentum Strengthen Investor Optimism - kalkine.ca
6.04%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):